Transcatheter aortic valve replacement (TAVR) has proven to be a safe, effective, and less
invasive approach to aortic valve replacement in patients with aortic stenosis. In patients …

Abstract Background: Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR)
has been shown to be feasible, yet the safety and efficacy in relation to native valve (NV) …

Highlights What is known? Transcatheter aortic valve replacement (TAVR) has become the
standard of care beside sur-gical valve replacement (SAVR) in the majority of patients with …

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger
and lower surgical risk patients. Given the longer life expectancy of these patients, the …

Background: Early experience with transcatheter aortic valve replacement (TAVR) within
failed bioprosthetic surgical aortic valves has shown that valve-in-valve (VIV) TAVR is a …

Background Surgical aortic valve replacement and transcatheter aortic valve replacement
(TAVR) are now both used to treat aortic stenosis in patients in whom life expectancy may …

Over the last decades, bioprosthetic heart valves (BHV) have been increasingly implanted
instead of mechanical valves in patients undergoing surgical aortic valve replacement …

Objectives The objectives of this study were to compare short‐and intermediate‐term clinical
outcomes, procedural complications, TAVR prosthesis hemodynamics, and paravalvular …

Introduction Bioprosthetic aortic valves are increasingly being utilized in a younger
population due to improved durability and possibility for future valve-in-valve replacement …

Abstract Background Valve‐in‐valve (ViV) transcatheter aortic valve replacement (TAVR)
offers an alternative to reoperative surgical aortic valve replacement. The short‐and …